Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum
This study has been completed.
First Received: September 12, 2005   Last Updated: September 24, 2008   History of Changes
Sponsored by: Johnson & Johnson Consumer & Personal Products Worldwide
Information provided by: Johnson & Johnson Consumer & Personal Products Worldwide
ClinicalTrials.gov Identifier: NCT00174499
  Purpose

The purpose of this research study is to evaluate the effects on existing tooth stain of nicotine gum. The study will enroll adults who have visible tooth staining.


Condition Intervention Phase
Dental Pellicle
Drug: 2 mg nicotine gum
Drug: 4 mg nicotine gum
Phase IV

Study Type: Interventional
Study Design: Non-Randomized, Open Label, Uncontrolled, Parallel Assignment
Official Title: An Open-Label Study on Nicorette Freshmint Gum, 2 MG AND 4 MG in Smokers With Visible Teeth Staining Motivated to Quit

Resource links provided by NLM:


Further study details as provided by Johnson & Johnson Consumer & Personal Products Worldwide:

Primary Outcome Measures:
  • The primary objective of this study was to assess, by using the MacPherson modification of the Lobene Stain Index, the amount of extrinsic tooth-stain reduction from Baseline while quitting smoking using Nicorette Freshmint gum [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To assess reduction in tooth-staining in relation to usage of gums [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]
  • To assess smoking status [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]
  • To assess safety [ Time Frame: 6 Weeks ] [ Designated as safety issue: No ]

Enrollment: 78
Study Start Date: July 2005
Study Completion Date: September 2005
Primary Completion Date: August 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
2 mg nicotine gum
Drug: 2 mg nicotine gum
2 mg nicotine gum
2: Experimental
4 mg nicotine gum
Drug: 4 mg nicotine gum
4 mg nicotine gum

Detailed Description:

This was a 6-week, open-label, single-center study conducted in 78 subjects who were smokers with visible staining of teeth and who were motivated to quit smoking through use of Nicorette Freshmint gum.

The subjects were assigned, per label instructions, to either Nicorette Freshmint gum 2 mg or 4 mg based on the number of cigarettes smoked per day. Subjects who smoked at least 25 or more cigarettes per day were assigned to the 4 mg gum group; those who smoked less than 25 cigarettes per day were assigned to the 2 mg gum group.

A total of 3 study visits were planned: Screening/Baseline, Week 2 and Week 6. A telephone screening prior to Baseline and the Screening/Baseline visit was performed to confirm subject eligibility. At each visit an oral examination, including a stain index measurement used to rate tooth-staining (MacPherson Modification of the Lobene Stain Index), was conducted; and smoking status and motivation to quit smoking were assessed. The safety evaluation at each visit included an oral tissue assessment in addition to assessment for any adverse events.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • daily smokers for at least one year
  • motivated to quit smoking
  • normal chewing ability
  • willing to refrain from a dental prophylaxis for the duration of the study
  • total extrinsic facial tooth stain score > or = to 28, according to the MacPherson Modification of the Lobene Stain Index

Exclusion Criteria:

  • < 20 natural teeth
  • inadequate oral hygiene
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00174499

Sponsors and Collaborators
Johnson & Johnson Consumer & Personal Products Worldwide
Investigators
Study Director: Elisabeth A Kruse, PhD JJCPPW
  More Information

No publications provided

Responsible Party: JJCPPW ( Joyce Hauze/Senior Project Manager )
Study ID Numbers: A6431088
Study First Received: September 12, 2005
Last Updated: September 24, 2008
ClinicalTrials.gov Identifier: NCT00174499     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Johnson & Johnson Consumer & Personal Products Worldwide:
Tooth stain

Study placed in the following topic categories:
Nicotine polacrilex
Neurotransmitter Agents
Nicotine
Nicotinic Agonists
Tooth Discoloration
Central Nervous System Stimulants
Peripheral Nervous System Agents
Cholinergic Agents

Additional relevant MeSH terms:
Nicotine polacrilex
Neurotransmitter Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Nicotinic Agonists
Physiological Effects of Drugs
Central Nervous System Stimulants
Cholinergic Agents
Pharmacologic Actions
Nicotine
Autonomic Agents
Therapeutic Uses
Ganglionic Stimulants
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on September 02, 2009